CoreLab Partners has introduced an imaging service designed for use of an independent central image review system for the diagnosis of early Alzheimer's disease. Michael Woehler, CoreLab's president and CEO, said the company plans to establish a team of health care providers equipped with the proper tools for improved evaluation of images from various advanced modalities, including PET and SPECT.